Mimedx (MDXG) Net Equity Issued and Repurchased (2011)
Mimedx's (MDXG) quarterly Net Equity Issued and Repurchased came in at -$3.7 million in Q4 2011, down 3476.65% quarter-over-quarter from $110867.0 in Q3 2011.
Powered by 
Analysis
Mimedx (MDXG) Net Equity Issued and Repurchased (2011) Analysis & Trends
Mimedx has disclosed Net Equity Issued and Repurchased across 1 years of filings, most recently posting -$3.7 million for Q4 2011.
- In Q4 2011, Net Equity Issued and Repurchased changed N/A year-over-year to -$3.7 million; the TTM figure through Sep 2012 stood at -$3.7 million (changed N/A YoY), while the FY2020 annual figure was $100.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased came in at -$3.7 million for Q4 2011 at Mimedx, down from $110867.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.4 million in Q2 2011 to a low of -$3.7 million in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | - |
| 10 | Mimedx | 670.99 Mn | 535.15 Mn | 44.38 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2011 | -3.74 Mn |
| Sep 30, 2011 | 110,867.00 |
| Jun 30, 2011 | 2.42 Mn |
| Mar 31, 2011 | 1.21 Mn |